https://www.science.org/content/blog-post/faked-crystallography Advertisement * * news * careers * commentary * Journals * Covid-19 Science Science * * * Log in * Become A Member [science] science [sciadv] science advances [sciimmunol] science immunology [scirobotics] science robotics [signaling] science signaling [stm] science translational medicine [spj-cover] science partner journals Quick Search anywhere Enter Search Term[ ] Quick Search in Journals Enter Search Term[ ] Quick Search in Journals Enter Search Term[ ] Quick Search in Journals Enter Search Term[ ] Quick Search in Journals Enter Search Term[ ] Quick Search in Journals Enter Search Term[ ] Quick Search in Journals Enter Search Term[ ] Searching: Anywhere AnywhereScienceScience AdvancesScience ImmunologyScience Robotics Science SignalingScience Translational Medicine Advanced Search Search Trending Terms: * covid-19 * climate * science policy * genome editing * batteries Log In Become A Member Quick Search anywhere Enter Search Term[ ] science.org * Custom publishing * collections * videos * podcasts * blogs * visualizations * prizes and awards * authors & reviewers * librarians * advertisers * about * help * * * * * * AAAS Logo * Terms of Service * Privacy Policy * Accessibility * Commentary Home * Opinion * Analysis * Blogs GET OUR E-ALERTS HomeCommentaryBlogsIn the PipelineFaked Crystallography Back To In the Pipeline * In the Pipeline Faked Crystallography * 29 Jul 2022 * By Derek Lowe * 2 min read * Comments Share: * Twitter * Linked In * Facebook * Reddit * Wechat * Email I'll admit that I didn't see this one coming: Retraction Watch is reporting that the Cambridge Crystallographic Data Center (CCDC), the world's main repository of small-molecule crystal data, is on the way to pulling nearly a thousand deposited crystal structures because they appear to have been faked. A preprint from earlier this year from David Bimler flagged what seems to be a paper-mill operation flooding out bogus papers on metal-organic frameworks: hundreds and hundreds of weirdly worded manuscripts on nonexistent MOFs and their imaginary applications, full of apparently randomly selected "references" to the rest of the literature. And these things depositited crystal data with the CCDC, which is the step that I really didn't expect. After all, anyone who studies the scientific literature has (especially in recent years) seen these auto-generated papers full of crap. But faked crystal structure files? That's nasty. The record of these papers shows a sudden jump in 2020 and 2021, leading Bimler to wonder: The dates paint a picture of accelerating publication, as if a small-scale cottage industry had been scaled up to a production line with a larger staff. One can imagine crystallographers initially ghostwriting manuscripts as a favour for friends, moonlighting from their day job, and becoming progressively more professional, though this must remain speculation. These things have appeared in a whole list of journals, with a good number showing up in Inorganic and Nano-Metal Chemistry, Journal of Structural Chemistry, Journal of Molecular Structure, Main Group Chemistry, and Zeitschrift fur Kristallographie - New Crystal Structures. These are not the most widely read journals in all of science, but they have been considered real places where real papers appear with real data. A few papers have appeared in even more general chemistry titles such as the Bulletin of the Chemical Society of Japan. There are also a few dozen papers that were shoveled into the Journal of the Iranian Chemical Society and the Arabian Journal of Chemistry, and a few that went into really obscure titles such as the Brazilian Journal of Medical and Biological Research. Apparently one of the highest-count titles for placement of these junkheaps is the Latin American Journal of Pharmacology, from Buenos Aires, and I can confidently state that I have never heard of that title in my life. What they're doing publishing scores of papers on metal-organic frameworks is beyond me, and it seems to be beyond Bimler's ken as well. He notes that the journal does not offer library subscriptions, and papers have to be bought for $50 each, so there are probably a number of them that haven't even been counted up yet. Retraction Watch reports that the CCDC doesn't pull things from its database until the background papers themselves have been retracted. For over 900 papers, that's going to take quite a while, at traditional journal-correction rates. So they've issued "Expressions of Concern" on their own part for these papers, which is not something you see a database like this doing. But it's a lot better than waiting for the journals to get their acts together, especially since the likes of the Latin American Journal of Pharmacology may in fact have no such coherence to collect in the first place. And I had not realized it, but there was a fake crystal data scandal back in 2010. That one perhaps gives some insights into how you fake such things: apparently the authors in those cases would take an actual set of crystallorgraphic data (somebody else's naturally!) and just step in and substitute some new metal atoms and the like. Voila, a new "compound" and a new CIF to deposit. In that round of fakery, it turned out that one structure had been used to generate eighteen supposed new ones, which is impressive in its way. Similar techniques have probably been used this time around, too; no doubt one could write a script to just auto-fake this stuff. To quote Samuel Johnson, "A man might write such stuff for ever, if he would but abandon his mind to it". One final note: the "authors" of all these current 992 papers are from Chinese medical institutions, most of them appearing only once. If anyone got a raise or promotion based on their publication record off this stuff, what a waste of money that was. . . About the author Derek Lowe Derek Lowe emailTwitter Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. --------------------------------------------------------------------- Comments Please enable JavaScript to view the comments powered by Disqus. IN THE PIPELINE Derek Lowe's commentary on drug discovery and the pharma industry. An editorially independent blog, all content is Derek's own, and he does not in any way speak for his employer. Advertisement YOU MAY ALSO LIKE 25 Jul 2022By * Derek Lowe Faked Beta-Amyloid Data. What Does It Mean? 7 Jun 2022By * Derek Lowe The Novavax Vaccine, Finally 11 May 2022By * Derek Lowe Paxlovid, Personally 23 Feb 2010By * Derek Lowe Things I Won't Work With: Dioxygen Difluoride View More Advertisement ARCHIVES Select Year: [2020] [January ] View Posts Related Jobs Advertisement RecommendedClose 9 Sep 2013By * Derek Lowe Exposing Faked Scientific Papers 15 Jun 2016By * Derek Lowe More on Scientific Reports, And on Faked Papers 12 Dec 2014By * Derek Lowe Guidelines For MOF Crystallography 25 Jul 2022By * Derek Lowe Faked Beta-Amyloid Data. What Does It Mean? Skip slideshow Follow Us * * * * * * * NEWS * All News * ScienceInsider * News Features * Subscribe to News from Science * News from Science FAQ * About News from Science * CAREERS * Careers Articles * Find Jobs * Employer Profiles * COMMENTARY * Opinion * Analysis * Blogs * JOURNALS * Science * Science Advances * Science Immunology * Science Robotics * Science Signaling * Science Translational Medicine * Science Partner Journals * AUTHORS & REVIEWERS * Information for Authors * Information for Reviewers * LIBRARIANS * Manage Your Institutional Subscription * Library Admin Portal * Request a Quote * Librarian FAQs * ADVERTISERS * Advertising Kits * Custom Publishing Info * Post a Job * RELATED SITES * AAAS.org * AAAS Communities * EurekAlert! * Science in the Classroom * ABOUT US * Leadership * Work at AAAS * Prizes and Awards * HELP * FAQs * Access and Subscriptions * Order a Single Issue * Reprints and Permissions * TOC Alerts and RSS Feeds * Contact Us Follow Us * * * * * * AAAS logo (c) 2022 American Association for the Advancement of Science. All rights reserved. AAAS is a partner of HINARI, AGORA, OARE, CHORUS, CLOCKSS, CrossRef and COUNTER. back to top * Terms of Service * Privacy Policy * Accessibility